|
|
Suppliers for
LY2109761
|
Properties | CAS |
700874-71-1 | Formula |
C26H27N5O2 |
|
7 Registered suppliers
More details are to be found here
More details are to be found here
Molecular Formula: C26H27N5O2 Molecular Weight: 441.52488 HS Code: 29349990
Molecular Formula: C26H27N5O2 Molecular Weight: 441.52488 HS Code: 29349990
Description : LY2109761 is a novel inhibitor of TGF-β receptor type I/type II kinases (IC50 = 69 nM), displaying antitumor activity. In vivo study demonstrated that LY2109761, in combination with gemcitabine, significantly reduced the tumor burden, prolonged survival, and reduced spontaneous abdominal metastases. - Molecular Weight :441.52
- Purity :> 98%
Molecular Formula : C26H27N5O2 Canonical SMILES : C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6 InChI : InChI=1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2 InChIKey : IHLVSLOZUHKNMQ-UHFFFAOYSA-N Synonyms : LY-2109761; 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
More details are to be found here
Description : LY2109761 is a novel inhibitor of TGF-β receptor type I/type II kinases (IC50 = 69 nM), displaying antitumor activity. In vivo study demonstrated that LY2109761, in combination with gemcitabine, significantly reduced the tumor burden, prolonged survival, and reduced spontaneous abdominal metastases. - Molecular Weight :441.52
- Purity :> 98%
Molecular Formula : C26H27N5O2 Canonical SMILES : C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6 InChI : InChI=1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2 InChIKey : IHLVSLOZUHKNMQ-UHFFFAOYSA-N Synonyms : LY-2109761; 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
More details are to be found here
Description : LY2109761 is a novel inhibitor of TGF-β receptor type I/type II kinases (IC50 = 69 nM), displaying antitumor activity. In vivo study demonstrated that LY2109761, in combination with gemcitabine, significantly reduced the tumor burden, prolonged survival, and reduced spontaneous abdominal metastases. - Molecular Weight :441.52
- Purity :> 98%
Molecular Formula : C26H27N5O2 Canonical SMILES : C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6 InChI : InChI=1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2 InChIKey : IHLVSLOZUHKNMQ-UHFFFAOYSA-N Synonyms : LY-2109761; 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
More details are to be found here
Detailed information on the suppliers of
LY2109761
|
Properties:
... more properties and specification on LY2109761
|
|
Privileged suppliers
Last update 2024-04-29
|